← Back to Clinical Trials
Recruiting NCT07127250

NCT07127250 Interest of Walking Sticks to Increase Walking Activity of People With Sagittal Imbalance of Spine

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07127250
Status Recruiting
Phase —
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Static Spinal Disorder
Study Type INTERVENTIONAL
Enrollment 35 participants
Start Date 2025-11-25
Primary Completion 2028-02

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Walking sticks

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 35 participants in total. It began in 2025-11-25 with a primary completion date of 2028-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this pilot study is to assess the impact of using walking sticks on walking perimeter in people with anterior spinal imbalance.

Eligibility Criteria

Inclusion Criteria: * Adult ≥ 50 years * VAS (Sagittal Vertical Axis, C7-S1, EoS (clinical follow-up)) \> 5cm * Able to do transfers alone * Able to walk 10 minutes or 400 meters in a row * Self-reported Walking difficulties * Person living at home * Person willing and consenting to participate in the study * Health insurance Exclusion Criteria: * Current use of walking sticks * Advanced and symptomatic osteoarthritis of the lower limbs * Static disorder of the fixed spine * Introduction of a straightening brace in the 3 months preceding the start of the study * Static disorder explained by infectious, tumoral, congenital or neurodegenerative pathologies * Uncompensated lower-limb length inequality (\> 2cm) * Lower limb motor deficit * Upper limb pathology preventing cane use * Proprioceptive or vestibular pathology * Inability to write, speak or read French * Cognitive and/or behavioral disorders * Participation in other research on spinal balance and/or gait, or that could influence these factors during the study period * People under tutorship or curatorship * Free state medical assistance

Contact & Investigator

Central Contact

Rémy FLECHON

✉ remy.flechon@aphp.fr

📞 01.58.41.41.41 Poste 18608

Principal Investigator

Alexandra ROREN

STUDY DIRECTOR

Assistance Publique - Hôpitaux de Paris

Frequently Asked Questions

Who can join the NCT07127250 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Static Spinal Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07127250 currently recruiting?

Yes, NCT07127250 is actively recruiting participants. Contact the research team at remy.flechon@aphp.fr for enrollment information.

Where is the NCT07127250 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT07127250 clinical trial?

NCT07127250 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Alexandra ROREN at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 35 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology